Drug Profile
RO 5428029
Alternative Names: RO5428029Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Roche
- Class Antivirals
- Mechanism of Action DNA-directed RNA polymerase modulators; Viral nonstructural protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hepatitis C
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Hepatitis-C in France (PO)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Hepatitis-C in Netherlands (PO)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Hepatitis-C(In volunteers) in USA (PO)